Andrew Godwin, PhD, deputy director of the University of Kansas Cancer Center, will lead the project, which will support four core facilities: quantitative omics, biobanking and biomarker validation, biomedical engineering and patient and community engagement.
“Precision medicine has the potential to change the landscape of how we provide care,” UKMC Executive Vice Chancellor Robert Simari, MD, said in a news release. “Receiving a grant of this size is remarkable and will enable our researchers to develop tailored treatments for all types of diseases.”
More articles on health IT:
AI may help detect ICU patient mobility, study shows
Some tech employees reportedly taking diabetes drug to improve health
JPMorgan Chase awards AI research grants to universities, PhD students
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
